ANDA 85164, held by Parke Davis. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 85164 (Chlordiazepoxide Hydrochloride), held by Parke Davis, was first approved by FDA on Aug 24, 1976, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 24, 1976 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlordiazepoxide Hydrochloride25MG ยท capsule;oral | Chlordiazepoxide Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters